Page last updated: 2024-11-04

sulfisoxazole and Breast Cancer

sulfisoxazole has been researched along with Breast Cancer in 1 studies

Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.

Research Excerpts

ExcerptRelevanceReference
" Here we identify sulfisoxazole (SFX) as an inhibitor of small extracellular vesicles (sEV) secretion from breast cancer cells through interference with endothelin receptor A (ETA)."3.91Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. ( Bae, JS; Baek, MC; Cho, YE; Im, EJ; Jee, JG; Jeong, MS; Jun, S; Jung, HS; Kang, KW; Kang, W; Kwon, TK; Lee, B; Lee, CH; Lee, JC; Lee, JE; Lee, JM; Moon, PG; Rangaswamy, GG; Ro, HJ; Seo, SY; Song, BJ, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Im, EJ1
Lee, CH1
Moon, PG1
Rangaswamy, GG1
Lee, B1
Lee, JM1
Lee, JC1
Jee, JG1
Bae, JS1
Kwon, TK1
Kang, KW1
Jeong, MS1
Lee, JE1
Jung, HS1
Ro, HJ1
Jun, S1
Kang, W1
Seo, SY1
Cho, YE1
Song, BJ1
Baek, MC1

Other Studies

1 other study available for sulfisoxazole and Breast Cancer

ArticleYear
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A.
    Nature communications, 2019, 03-27, Volume: 10, Issue:1

    Topics: Animals; Anti-Infective Agents; Breast Neoplasms; Cell Line, Tumor; Endosomes; Extracellular Vesicle

2019